News UK's Artios raises $84m to further DDR drug research Management team led development of AZ's PARP drug Lynparza
News NICE okays Pfizer blood cancer drug Besponsa after appeal Life-line drug cancer drug finally available on NHS
News Regeneron forges CAR-T R&D partnership with bluebird bio Deal combines Regeneron's receptor tech with CAR-T biotech's expertise
Partner Content Partner Content Immuno-Oncology challenges include identifying patients befo... Challenges facing Immuno-Oncology industry
Cancer Accord’s biosimilar Pelgraz poised for approval Cancer biosimilar drug Pelgraz is poised to hit the market after receiving a positive opinion by the Committee for Medicinal Products for Human Use (CHMP).
News EU regulators reject new use for Opdivo, as Keytruda edges a... Keytruda begins to win battle of the immunotherapies
News Adcendo raises $135m for cancer ADCs, and other financings Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
